Last week Pixels & Pills’ editor Briana Campbell had the pleasure of sitting down for a Skype chat (so the quality is a little lower than our normal, professional videos) with Dr. Darshan Kulkarni (@FDALawyers) of the Kulkarni Law Firm in Philadelphia. And while the questions answered in the conversation don’t constitute legal advice and [...]
Tags:#hcsm·@FDALawyers·Darshan Kulkarni·FDA·FDA Guidance·information·innovation·legal·Legal Issues·marketing·resources·social media·social media guidance·social media guidelines·Trends·Video
by Briana Campbell (@MsMatchGirl)
By now, you’ve all had time to review the FDA’s draft guidance on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices. And you’ve had time to read the multitude of responses that came after (if you didn’t, Fabio Gratton has compiled many of them for you). And, [...]
Tags:electronic media·emerging media·engagement·FDA·FDA Guidance·FDA guidelines·information·innovation·Pharma·Pharmaceutical industry·social media·Social network·strategy·Trends
by DJ Edgerton (@wiltonbound)
The question seems almost nonsensical at first – your Twitter followers may be really outstanding people, but they’re not organic chemists or researchers. And your Facebook fans, while devoted, probably do not, generally speaking, know how to move a new drug through the FDA approval process.
Just the same, it’s a mistake to [...]
Tags:Compliance·data·digital strategy·Digital Tools·Education·engagement·epatient·FDA·information·innovation·Legal Issues·marketing·Pharma·Pharmaceutical industry·R&D·research and development·social media·Social network·strategy·technology·Trends·user needs
by DJ Edgerton (@wiltonbound)
Like Tom Petty sang, the waiting is the hardest part. But is it necessary for pharma to continue holding out for social media guidelines before implementing digital strategy?
With more than 75 percent of people using the Internet, social media is an important component of business communication. Yet, many pharmaceutical companies are still [...]
Tags:#fdasm·FDA·FDA Guidance·FDA guidelines·social media·social media strategies·social media strategy·social networks
by Sven Larsen
#Adaptordie is an apt hashtag to sum up the teachings of digital-media pundit Brian Solis. It’s also an apt hashtag to describe the current state of affairs in the pharmaceutical industry.
Solis’s new book, The End of Business as Usual, a follow-up to the popular Engage, focuses on this need of business to change the old ways and [...]
Tags:digital strategy·Digital Tools·Facebook·FDA·healthcare·innovation·marketing·Pharma·Pharmaceutical industry·social media·social networks·Trends
by DJ Edgerton (@wiltonbound)
How much of a role does social media play in influencing policymakers? And how much of a role can – or should – marketing play in crafting those messages for pharmaceutical companies?
It’s a tough question, but before we get to it, take a moment to listen carefully. Hear that high-pitched, faint screaming [...]
Tags:communications·elected officials·Facebook·FDA·patient needs·Pharma·Pharmaceutical industry·politics·social media·social networks·Twitter
As we keep talking (and talking and talking) about and waiting (and waiting and waiting) for FDA Guidelines for social media usage, we thought it would be fun to visit this video, from nearly two years ago.
Do you remember this time? Are you still waiting for guidance or are you pushing the boundaries without it?
Tags:FDA·FDA Guidance·FDA guidelines·social media·Social network
In our final interview from the Digital Innovation for Pharma Conference, Darshan Kulkami, principal of the Kulkami Law Firm talks about some of the latest news regarding social media and compliance and what it means for the pharma industry.
Tags:#efp·Compliance·Darshan Kulkami·digital innovation for pharma·FDA·Pixels & Pills·social media
by Jason Brandt (@jasondmg3)
I don’t understand any of this stuff.
Who has the time to really use this stuff anyway?
No real business can afford to have employees wasting their time on this stuff when they should be busy working.
It’s just a geek thing. Nobody with a life really uses this stuff.
It’s just a kid thing. [...]
Tags:business·communication·Digital Tools·Education·engagement·Facebook·FDA·Health care·healthcare·information·innovation·marketing·Patients·Pharmaceutical industry·social media·Social network·Trends
by DJ Edgerton (@wiltonbound)
What do Lady Gaga, Arnold Schwarzenegger and Charlie Sheen have in common? They’re some of the most popular celebrity masks for party revelers this Halloween season. While industry luminaries may not dress up for tricks and treats, many pharma brands are hiding behind their own masks, limiting the ROI in their digital [...]
